Difference between revisions of "OctPGMSGp pathway control state"
From Bioblast
| Line 10: | Line 10: | ||
|info=[[MiPNet21.06 SUIT reference protocol]] | |info=[[MiPNet21.06 SUIT reference protocol]] | ||
}} | }} | ||
{{MitoPedia concepts}} | {{MitoPedia concepts | ||
|mitopedia concept=Respiratory state, SUIT state | |||
}} | |||
{{MitoPedia methods}} | {{MitoPedia methods}} | ||
{{MitoPedia O2k and high-resolution respirometry | {{MitoPedia O2k and high-resolution respirometry}} | ||
}} | |||
{{MitoPedia topics}} | {{MitoPedia topics}} | ||
== PGMSOctGp(L) == | == PGMSOctGp(L) == | ||
Revision as of 16:21, 13 May 2016
- high-resolution terminology - matching measurements at high-resolution
OctPGMSGp pathway control state
Description
PGMSOctGp: Pyruvate & Glutamate & Malate & Succinate & Octanoylcarnitine & Glycerophosphate.
MitoPathway control: CI&II&FAO&GpDH
SUIT protocol: SUIT-RP2
This substrate combination supports convergent electron flow to the Q-junction.
Abbreviation: PGMSOctGp
Reference: MiPNet21.06 SUIT reference protocol
MitoPedia concepts:
Respiratory state,
SUIT state
PGMSOctGp(L)
PGMSOctGp(P)
PGMSOctGp(E)
- SUIT-RP2_8Gp: 1D 2Oct 3Mtit 3c (3NADH) 4P 5G 6S 7U 8Gp 9Rot 10Ama 11Tm 12Azd
